T cell memory and the recall response

The Revised Authoritative Guide To Vaccine Legal Exemptions

Vaccines Have Serious Side Effects

Get Instant Access

The development of FACS staining approaches utilizing tetrameric complexes [2] of MHC class I glycoprotein + peptide (tetramers) has greatly facilitated the analysis of both the effector and memory phases of virus-specific CD8+ T cell responses [20, 40]. This technology has moved more slowly for the CD4+ T cell subset [5, 6, 58], partly because the comparable MHC class II + peptide reagents are more difficult to produce [129], and partly because CD4+ T cell responses can tend to be both more diverse and smaller in magnitude.

The most useful techniques for analysing CD4+ T cell memory depend on the measurement of IFN-y production by peptide-stimulated lymphocytes, measured either in a flow cytometric assay or by ELISpot analysis after 24-48 hours of in vitro culture [66]. Persistent CD4+ T cell memory is, for example, found for adenoviruses in healthy humans [89]. Lack of progression to AIDS has been correlated with the continued presence of more HIV-specific IFN-y than IL-10-producing CD4+T cells in the peripheral circulation [91]. Priming CD4+ T cell memory to a prominent Sendai virus epitope led to a more rapid antibody response and enhanced virus clearance [136]. Low-level yHV68 persistence induced continuing CD4+ and CD8+ T cell responses that substantially prevented the establishment of further lytic, but not latent, infection following respiratory challenge of antibody-negative, |xMT mice with the same virus [4]. Immune CD4+ and CD8+ T cells contributed to this protective effect in an additive way. Though adoptively-transferred CD4+ and CD8+ T cells promoted the recovery of |xMT mice from influenza virus infection, the CD8+ set was clearly more effective in this regard [51]. In general, we understand less about CD4+ than CD8+ T cell memory.

Persistent CD8+ T cell memory can be demonstrated in both mice and humans following a single exposure to an inducing virus [38, 56, 61, 65, 78]. These long-lived T cells and their progeny express high levels of telomerase activity [57] though, under conditions of continuing antigen stimulation, telomere length may be shortened to the extent that clonal survival is impaired [102, 125]. The maintenance of CD8+ T cell memory reflects the survival of clontotypes expanded during the initial, antigen driven phase of the host response [123], but does not seem to require either the persistence of the inducing epitope or even the continued presence of MHC class I glycoprotein [59, 85]. What does seem to be important is exposure to the cytokines IL-7 and IL-15, both during the acute response phase and in the long term. [17, 64, 107, 119, 135].

The recall of CD8+ T cell memory can certainly provide a measure of protection against virus challenge [27], a possibility that is particularly attractive for viruses that vary their surface glycoproteins as a consequence of antibody-mediated selection pressure. Virus-specific CD8+ T cell responses tend to be directed at peptides derived from conserved, internal proteins [12,130], a situation that may be quite different from that found with CD4+ T cell responses [22]. This cross-reactivity is, for instance, a good reason for thinking about the use of live influenza vaccines, combined with other mechanisms for boosting CTL memory [29, 43].

The problem with relying on the recall of CD8+ T cell memory for protection is that, though the injection of peptide-pulsed cells is generally associated with rapid elimination [9], the recall of effective CD8+ T cell memory to a distal site of virus growth is substantially delayed [35, 47]. When memory T cell numbers are at what might be thought of as physiological levels, there is a clear necessity for further proliferation in the lymphoid tissue, followed by emigration into the blood and localization to the target organ [48]. Even when memory T cell numbers are very high in, for example, the lung, a rapidly growing influenza A virus will still become fully established before CD8+ T cell effectors operate to eliminate the infected cells and control the growth of the pathogen [29].

Thus, though vaccines directed at promoting CD8+ T cell memory can limit the damage done by lytic viruses that do not have a capacity for persistence, they seem unable to prevent the establishment of persistent infections [4, 118]. This has been clearly demonstrated for monkeys primed with candidate HIV vaccines [3, 10]. The T cells function for a time to limit the extent of virus replication, but escape variants eventually emerge [11].

Was this article helpful?

0 0

Post a comment